Fundraising Fox
Sirius Neosight
Lyon, FR · 3 known investors
Find your way into Sirius Neosight
Sign up to find every way you can get introduced to Sirius Neosight
- Your email: who you already know at Sirius Neosight, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sirius Neosight team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Sirius NeoSight develops a patented technology that measures cell membrane fluidity using a fluorescent molecule to detect, isolate and characterise Circulating Tumour Cells (CTCs) from blood samples. Aimed at oncologists, the technology supports early cancer detection, monitoring of recurrence and treatment resistance, and personalised therapy selection for metastatic and aggressive cancers.
Founders & leadership
JL
Jean-Guillaume LafayCo-founder
SL
Stéphane LegasteloisCo-founderStéphane Legastelois holds a PhD in immunology from the University of Lyon and completed management training at EM Lyon Business School. He brings 25 years of life sciences experience, including roles as R&D manager and sales & marketing manager at Merck, and has founded or led multiple biotechnology companies including Indicia Biotechnology, a contract research organization focused on assay development and immunogenicity assessment.
Investors · 3
Frequently asked questions
- What does Sirius Neosight do?
- Sirius NeoSight develops a patented technology that measures cell membrane fluidity using a fluorescent molecule to detect, isolate and characterise Circulating Tumour Cells (CTCs) from blood samples. Aimed at oncologists, the technology supports early cancer detection, monitoring of recurrence and treatment resistance, and personalised therapy selection for metastatic and aggressive cancers.
- Who founded Sirius Neosight?
- Sirius Neosight was founded by Arnaud Vigneron, David Gueyrard, Jean-Guillaume Lafay, Stéphane Legastelois.
- Who are Sirius Neosight's investors?
- Sirius Neosight's investors include Angels Santé, Octalfa, GO Capital.
- Where is Sirius Neosight headquartered?
- Sirius Neosight is headquartered in Lyon, FR.